Company profile: Nomic Bio

1.1 - Company Overview

Nomic Bio

Headquarter: Canada

Founded: 20XX🔒

Employees: 100-500🔒

🌐 Website

Company description

Provider of a proteomic technology platform leveraging DNA nanotechnology to understand, detect, and treat diseases.

Products and services

🔒

Key contacts

🔒

Financial details

🔒

1.2 - Competitors and similar companies to Nomic Bio

ClinPhone

HQ: United Kingdom Website

Description: Provider of clinical technology, headquartered in Nottingham, United Kingdom, offering ClinPhone RTSM, part of the Perceptive MyTrials eClinical platform, for randomization and trial supply management.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full ClinPhone company profile →

Wisecube

HQ: United States Website

Description: Provider of a hybrid cloud graphical AI platform focused on life science research acceleration.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Wisecube company profile →

SnapGene

HQ: United States Website

Description: Provider of software to plan, visualize, and document DNA cloning and PCR.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full SnapGene company profile →

RadMD

HQ: United States Website

Description: Provider of imaging contract research services (iCRO), delivering high-value imaging expertise through 17 staff and over 250 contracted clinical trial readers. Applies market experience and advanced systems to reduce costs and improve efficiency in drug and device development for pharmaceutical/biotech and contract research organisations.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full RadMD company profile →

Veracity Logic

HQ: United States Website

Description: Provider of interactive response technology solutions for pharma and biotech, featuring a configurable IRT/RTSM platform for patient randomization and trial supply management. Capabilities include mid-study amendments, eligibility and stratification, re-randomization, site shipments, inventory control, kit tracking and expiration, blinded/unblinded batch handling, depot-to-site supply management, and integration with Veeva Development Cloud and third-party apps.

Rationale: This competitor operates in a highly similar market segment with overlapping features.

Company type: Private company
Employees: ●●●●●
Total funding raised: $●●●m
Backers: ●●●●●●●●●●
Acquisitions: ●●

View full Veracity Logic company profile →

🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒

🔒 View all strategic buyers with complete profiles

Start Free Trial →

2.2 - Strategic buyer groups for Nomic Bio

🔒

Buyer group 1: ████████ ████████

●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 2: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔒

Buyer group 3: ████████ ████████

●● companies

Key Products: ████████, ████████, ████████, ████████

🔒 View all companies in this group

Request Free Trial Now →

🔓 Unlock all detailed buyer group breakdowns with complete company profiles

Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Nomic Bio

Buyout Funds
50+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US buyout funds investing in Nomic Bio's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe buyout funds in Nomic Bio's sector and industry vertical
View Funds →

2.2 - Growth funds investing in similar companies to Nomic Bio

Growth Equity Funds
40+ funds

🔒

🔒

🔒

🔒

🔒 🇺🇸 Top US growth equity funds investing in Nomic Bio's sector and industry vertical
View Funds →
🔒 🇪🇺 Top Europe growth equity funds investing in Nomic Bio's sector and industry vertical
View Funds →

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Nomic Bio

4.2 - Public trading comparable groups for Nomic Bio

🔒

Comparable group 1: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 2: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔒

Comparable group 3: ████████ ████████
●● companies

Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████

Key Metrics: Avg EV/Revenue: ●.●x, Avg Growth: ●●%

Revenue growth

Median

15.7%

2025E

16.0%

2026E

EBITDA margin

Median

28.2%

2025E

28.6%

2026E

Cash EBITDA margin

Median

27.6%

2025E

28.0%

2026E

EV/Revenue

Median

8.4x

2025E

6.8x

2026E

EV/EBITDA

Median

28.9x

2025E

24.4x

2026E

EV/Cash EBITDA

Median

29.0x

2025E

25.5x

2026E

🔒 View all companies in this group
Request Free Trial Now →

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Nomic Bio

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA

🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Nomic Bio

What does Nomic Bio do?

Nomic Bio is a provider of a proteomic technology platform leveraging DNA nanotechnology to understand, detect, and treat diseases.

Who are Nomic Bio's competitors?

Nomic Bio's competitors and similar companies include ClinPhone, Wisecube, SnapGene, RadMD, and Veracity Logic.

Where is Nomic Bio headquartered?

Nomic Bio is headquartered in Canada.

How many employees does Nomic Bio have?

Nomic Bio has 1,000 employees 🔒.

When was Nomic Bio founded?

Nomic Bio was founded in 2010 🔒.

What sector and industry vertical is Nomic Bio in?

Nomic Bio is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Nomic Bio

Who are the top strategic acquirers in Nomic Bio's sector and industry

Top strategic M&A buyers and acquirers in Nomic Bio's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Nomic Bio?

Top strategic M&A buyers groups and sectors for Nomic Bio include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Nomic Bio's sector and industry vertical

Which are the top PE firms investing in Nomic Bio's sector and industry vertical?

Top PE firms investing in Nomic Bio's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Nomic Bio's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Nomic Bio's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Nomic Bio's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Nomic Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Nomic Bio's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Nomic Bio?

The key public trading comparables and valuation benchmarks for Nomic Bio include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Nomic Bio for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Nomic Bio with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Nomic Bio's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Nomic Bio with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Nomic Bio's' sector and industry vertical?

Access recent funding rounds and capital raises in Nomic Bio's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Nomic Bio

Start Free Trial Book a Demo